Activity

  • The Golden Age of Life Sciences Innovation Needs Smarter Data

    Jim Cahill
    There exists an interesting tension in the life sciences industry; while people have access to more treatments for more maladies than at any other time in human history, there is also increasing pressure to deliver new, innovative treatments. For evidence, simply look to the massive wave of innovation happening in the personalized medicine space. The […] The post The Golden Age of Life Sciences Innovation Needs Smarter…

  • Seamless Automation for a Personalized Future

    Jim Cahill
    It’s hard to discuss the life sciences today without talking about advanced therapeutics and personalized medicine. We are currently in a period of massive innovation that will reshape the delivery of medicine for decades to come. Where once pharmaceutical companies were laser focused on blockbuster drugs, today they are exploring more targeted therapeutic research that […] The post Seamless Automation for a Personalized…

  • Advancing Life Sciences Automation: Insights from Emerson Exchange 2025

    Jim Cahill
    At the Emerson Exchange 2025 Conference in San Antonio, Texas, Emerson’s Michalle Adkins collected feedback from the Life Sciences team on their Meet the Experts session. The key reminder for participants, customers, Impact Partners, and Emerson subject matter experts was that we are all in this together, working hard to ultimately provide therapies to patients. A technology roadmap was shared, highlighting the path to…

  • Raising the Bar for Flow Measurement: My Conversation on Control Amplified

    Jim Cahill
    Flow measurement may not always make headlines, but for industries like oil and gas, chemical manufacturing, and life sciences, it’s the cornerstone of operational excellence. I recently had the pleasure of joining Len Vermillion on the Control Amplified podcast to talk about how Emerson’s Micro Motion ELITE Coriolis flow meters are redefining what’s possible in this space. Listen to the episode here . Precision That…

  • Sustainability in Life Sciences: How Automation is Driving Carbon Reduction

    Jim Cahill
    As the global push toward decarbonisation intensifies, the life sciences industry faces the dual challenge of reducing emissions while maintaining the quality and availability of life-saving therapies. The stakes are high—but so are the opportunities. A recent white paper by Emerson explores how automation and digitalisation can help life sciences manufacturers reduce their carbon footprint —without disrupting core…

  • Teams of Life Savers Partnering to Accelerate and Deliver Therapies Podcast

    Jim Cahill
    Manufacturers in the Life Sciences sector are increasingly challenged by the advancement of advanced therapies and personalized medicines, as well as the rapidly advancing technology landscape. Emerson’s Jordan Johnson and Rachel Wright join me to discuss these challenges and the role of Emerson and its “Life Savers,” who work closely with them to address and overcome these challenges. Give the podcast a listen, and…

  • ​​​Solutions for Advanced Therapy Medicinal Products​

    Jim Cahill
    Emerson’s Bruce Greenwald , Christian Berg , and David Gray collaborated to present “Solutions for Advanced Therapeutics” at the Emerson Exchange 2025 Conference. Here is their presentation abstract.   ATMPs hold incredible potential to treat and cure life-threatening diseases, but managing the complex operations required for these therapies presents unique challenges. From precise control of patient-specific materials…

  • Unlocking the Potential of Autologous Cell & Gene Therapy Through Digital Transformation

    Jim Cahill
    Autologous and personalised cell and gene therapies (CGTs) represent one of the most promising frontiers in modern medicine offering curative potential for conditions once deemed untreatable. However, realising their full potential at scale remains a complex challenge for life sciences manufacturers. Unlike traditional pharmaceuticals, autologous CGTs require a scale-out approach managing multiple small, patient-specific…

  • Accelerating mRNA Therapy Production with Digital Innovation

    Jim Cahill
    Messenger RNA (mRNA) therapies are shaping the future of medicine from personalized vaccines to treatments for rare diseases. Yet, producing these therapies at scale remains a significant challenge due to the complexity of manufacturing processes, regulatory hurdles, and the need for precise, high-quality operations. Download our white paper Digital Excellence in Nuclear Acid Therapy to explore how digital tools can support…

  • Unlock the Power of Sustainable & Efficient Measurement Instrumentations in Life Sciences

    Jim Cahill
    In today’s rapidly evolving world, achieving sustainability has become a pivotal goal, especially in industries like life sciences, where energy efficiency and emission reduction are critical. Emerson’s innovative measurement instrumentations are at the forefront of enabling these advancements. Let’s explore how these cutting-edge solutions are helping life sciences industries drive sustainability and operational efficiency…

  • Unlocking Value Trapped in OT Data Podcast

    Jim Cahill
    The complexity of operating manufacturing and production facilities continues to grow. Data is abundant but often siloed in many different applications. The need to drive improvements in safety, efficiency, quality and reliability often requires data from these many divergent sources. In this Emerson Automation Experts podcast, Hamza Malik shares a solution to these silos of data, to bring them together to turn data…

  • Managing process knowledge throughout drug development and manufacturing

    Jim Cahill
    Digital transformation can be described as the integration of digital technology to create new business processes to meet changing market requirements. Within the life sciences industry, the market is demanding accelerated development and availability of new therapies. Digital transformation is helping the industry by providing the opportunity to execute tasks throughout the product development chain more efficiently…

  • Transformación de las ciencias de la vida con Boundless Automation

    Jim Cahill
    El sector de las ciencias de la vida está experimentando un cambio sísmico, impulsado por avances científicos revolucionarios, modalidades terapéuticas emergentes y una rápida evolución tecnológica. Descargue el artículo técnico «A Journey to Boundless Automation in Life Sciences» para descubrir todo el potencial de Boundless Automation en ciencias de la vida. Sin embargo, las organizaciones se enfrentan a un doble…

  • Transforming Life Sciences with Boundless Automation

    Jim Cahill
    The life sciences industry is undergoing a seismic shift, driven by groundbreaking scientific breakthroughs, emerging therapeutic modalities, and rapid technological evolution. Download “ A Journey to Boundless Automation in Life Sciences” whitepaper   to discover the full potential of Boundless Automation in life sciences. Learn how to break through data silos, implement AI-driven tools, and achieve a seamless transition…

  • For Life Sciences Data, Context is Critical

    Jim Cahill
    As systems become increasingly interconnected, we talk more and more about the importance of data and, more specifically, the need to get data to the right people, in the right format, at the right time, wherever they may be. This initiative has become even more imperative as operational technology (OT) and information technology (IT) converge. No longer are OT assets siloed and air-gapped by default. Today, OT systems…

  • Driving Digital Transformation in Life Sciences: Key Opportunities and Challenges

    Jim Cahill
    The life sciences industry stands at a critical juncture, with digital transformation offering a path to greater innovation, efficiency, and regulatory compliance. To dive deeper into strategies for driving digital excellence in life sciences, download our comprehensive whitepaper: ⁠ Download the Whitepaper: “Digital Excellence in Life Sciences” Integrating digital solutions across research, manufacturing, and data management…

  • Simplifying Recipe Creation in the Life Sciences Podcast

    Jim Cahill
    Manufacturing execution systems have been indispensable in the pharmaceutical and biopharmaceutical industries to orchestrate manufacturing operations among the various enterprise and plant control and analytical systems. As the industry rapidly changes and needs to provide more personalized medicines and therapies, simpler, lighter-weight recipe creation and workflow management applications are required. In this…

  • Saving the Environment While Saving Lives

    Jim Cahill
    The push for more sustainable operations around the globe has touched nearly every industry, and the life sciences are no exception. Manufacturing teams now need to carefully manage waste, energy use, water use, and emissions on top of all their existing responsibilities. Whether this responsibility falls on a massive organization or a small startup company , it creates headaches and complexity that distract teams from…

  • Manufacturing Execution Systems for Greater Digital Maturity Podcast

    Jim Cahill
    Manufacturers in the Life Sciences industry are challenged with changing trends and the move to more personalized medicine solutions. Manufacturing execution systems (MES) play a critical role in optimizing the lifecycle of the production process from order through release for sale. Johan Zebib joins me in this Emerson Automation Experts podcast to share how MES addresses many of the challenges for higher quality, and…

  • Enabling Boundless Automation in the Life Sciences Industry

    Jim Cahill
    Boundless Automation is Emerson’s vision for an industrial architecture built on a consistent, cohesive software ecosystem from intelligent field devices to the edge and to the cloud—integrating operations to make all data instantly accessible, understandable, and usable for analytics, innovation, and performance improvement. Several of our recent Life Sciences podcasts have featured conversations about the rapid shifts…

  • DeltaV PKM for One-Click Tech Transfer Podcast

    Jim Cahill
    The technology transfer process for manufacturers in the Life Sciences industry has been traditionally a slow and cumbersome process to scale up from research and development to commercial production. Capturing the process knowledge along the way and making changes can slow down the overall process. In this Emerson Automation Experts podcast, Bob Lenich joins me to discuss how the Process Knowledge Management (PKM)…

  • Life Sciences and Automation Companies Deliver the Future—Together

    Jim Cahill
    In the life sciences, bringing treatments to market quicker is no longer a bonus. Today, accelerating the treatment development pipeline is an expectation—arguably a core value—of the world’s most respected pharmaceutical companies. The pipeline for the COVID vaccine showed us that it was possible to operate differently , and companies around the globe have not only taken note; they’ve taken action . However, accelerating…

  • Tailoring Automation for Tailored Medicines

    Jim Cahill
    The life sciences industry is changing rapidly. Where once companies were focused on developing blockbuster treatments and manufacturing them as quickly and safely as possible, today, personalized medicine has changed that landscape. Now life sciences companies are looking at specialized treatments like cell and gene therapies which are developed and manufactured quite differently from those traditional blockbuster drugs…

  • Technology and Strategy Deliver Data Integrity

    Jim Cahill
    As the landscape of pharmaceutical manufacturing has changed in the last few years, one exciting shift has a distinct possibility of being a game changer in coming decades. Regulatory agencies have increasingly begun to recognize the importance of automation technologies, and, as a result, have incorporated more automation into their guidelines for good manufacturing practices (GMP). This trend aligns with industry’s…

  • Technology and Strategy Deliver Data Integrity

    Jim Cahill
    As the landscape of pharmaceutical manufacturing has changed in the last few years, one exciting shift has a distinct possibility of being a game changer in coming decades. Regulatory agencies have increasingly begun to recognize the importance of automation technologies, and, as a result, have incorporated more automation into their guidelines for good manufacturing practices (GMP). This trend aligns with industry’s…

This is the official online community site of the Emerson Exchange, a forum for the free exchange of non-proprietary information among the global user community of all Emerson's products and services. Our goal is to improve the efficiency and use of automation systems and solutions employed at members’ facilities by sharing our knowledge, experiences, and application information.

Community Guidelines | Legal Information | Privacy Policy | Contact Community Manager

Website translation provided by Website Translator

© 2015-2026 Emerson Exchange. All rights reserved.